Výsledky vyhledávání

Akademický článek

An Atypical Case of Extreme Polypharmacy

Autor: Veronin MA

Publikováno v: Drug, Healthcare and Patient Safety, Vol Volume 14, Pp 19-26 (2022)

Michael A Veronin Social and Administrative Sciences, Department of Pharmaceutical Sciences and Health Outcomes, The University of Texas at Tyler, Ben and Maytee Fisch College of Pharmacy, Tyler, TX, 75799, USACorrespondence: Michael A Veronin, Socia

Externí odkaz: https://doaj.org/article/18e169b00004477ea7d0937e92090d67

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P-014 Reperfusion catheter malfunction during stroke intervention: an analytical review of the FDA’s maude database

Autor: R De Leacy, B Gershon, D Bageac

Publikováno v: Oral poster abstracts.

Background In December 2020, the JET7 Xtra Flex reperfusion catheter was voluntarily recalled after reports of injury and death associated with device malfunction. The FDA’s MAUDE (Manufacturer and User Facility Device Experience) database aggregat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e80043bb1cef2ef3926593264051e176
https://doi.org/10.1136/neurintsurg-2021-snis.50

Zobrazit plný text záznamu

Reporting of adverse drug events in the Veterans Health Administration for patients whose treatment with empagliflozin or apixaban was discontinued

Autor: Xinhua Zhao, Anthony Au, Francesca E. Cunningham, Paul M Fina, Von R. Moore, Sherrie L. Aspinall, Peter A. Glassman

Publikováno v: American Journal of Health-System Pharmacy. 77:22-32

PurposeTo examine the reporting rates of adverse drug events (ADEs) with apixaban and empagliflozin as reports move up to the next level of spontaneous reporting.MethodsThis was a retrospective cohort study of outpatients who discontinued apixaban or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b66e71781fd1055022942d9a08d5152e
https://doi.org/10.1093/ajhp/zxz261

Zobrazit plný text záznamu

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System

Autor: Matthew S. Duprey, Keith B. Hoffman, Christopher Madias, Mo Dimbil, Nada S. Al-Qadheeb, Jonathan Weinstock, John W. Devlin, Nick O'Donnell

Publikováno v: Drugs-Real World Outcomes, Vol 6, Iss 3, Pp 141-149 (2019)
Drugs-Real World Outcomes

Background Serious cardiovascular adverse events (SCAEs) associated with intravenous sedatives remain poorly characterized. Objective The objective of this study was to compare SCAE incidence, types, and mortality between intravenous benzodiazepines

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e401b8c601a8f21e2ebbbaa4ff45c0b
http://link.springer.com/article/10.1007/s40801-019-00161-y

Zobrazit plný text záznamu

Fluoroquinolones: A hot topic for pharmacists and the Food and Drug Administration’s Division of Drug Information

Autor: Danielle M. Molnar, Mary Kremzner

Publikováno v: Journal of the American Pharmacists Association. 59:13-16

Objectives The Division of Drug Information (DDI) within the U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research receives telephone calls, e-mails, and letters from patients and industry. The consistently high numb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79acef925ef6fd657045f92dc38c3b22
https://doi.org/10.1016/j.japh.2018.08.011

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání